Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

(via TheNewswire), IVITF, IMH,8IS VANCOUVER, BC, February 7, 2017 INVICTUS MD STRATEGIES CORP. ( Invictus MD or the Company ) (CSE: IMH; OTC: IVITF; FRA: 8IS) ispleased to announce that on February 6, 2017 it hadentered into a binding letter of intent ( LOI ) for an option to acquire 100% (the Option ) of the outstanding shares of a Late Stage Applicant (the OptionCo ) under the Access to Cannabis for Medical Purposes Regulations ( ACMPR ) from its current shareholders (the Vendors ). In early January
http://bit.ly/2lmKOgg